Kristina Aaltonen

发表

Co-targeting of the PI3K pathway improves the response of BRCA1 deficient breast cancer cells to PARP1 inhibition.

H. Cunliffe, I. Hedenfalk, N. Loman, 2012, Cancer letters.

The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence

K. Pietras, P. Bendahl, Kristina Aaltonen, 2018, Breast Cancer Research and Treatment.

Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort

P. Bendahl, Kristina Aaltonen, L. Rydén, 2016, BMC Cancer.

Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis

P. Bourgine, B. Porse, Kristina Aaltonen, 2022, Science Translational Medicine.

Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma

R. Nilsson, J. Bergquist, A. Schulze, 2021, iScience.

Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma

D. Gisselsson, K. Wennerberg, K. Pietras, 2020, Science Translational Medicine.

Evolution of Estrogen Receptor Status from Primary Tumors to Metastasis and Serially Collected Circulating Tumor Cells

P. Bendahl, Kristina Aaltonen, L. Rydén, 2020, International journal of molecular sciences.

Transurethral bladder tumor resection can cause seeding of cancer cells into the bloodstream.

O. Patschan, Kristina Aaltonen, L. Rydén, 2015, The Journal of urology.

Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance

J. Karlsson, D. Gisselsson, Kristina Aaltonen, 2022, bioRxiv.

Patient-derived models: Advanced tools for precision medicine in neuroblastoma

Kristina Aaltonen, D. Bexell, A. Adamska, 2023, Frontiers in Oncology.

Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment

L. Saal, N. Loman, Kristina Aaltonen, 2019, Breast Cancer Research and Treatment.

Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer

P. Bendahl, Kristina Aaltonen, L. Rydén, 2020, Scientific Reports.

Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial

N. Loman, P. Bendahl, Kristina Aaltonen, 2018, Breast Cancer Research.

Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy

Lisa Rydén, P. Bendahl, Kristina Aaltonen, 2017, Oncotarget.

Anti-tumor effects of rigosertib in high-risk neuroblastoma

J. Karlsson, D. Gisselsson, K. Pietras, 2021, Translational oncology.

Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression

M. Fernö, K. Lövgren, P. Bendahl, 2020, Breast Cancer Research and Treatment.

Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients

Helena Jernström, Lisa Rydén, S. Gruvberger-Saal, 2015, PloS one.

Laser capture microdissection (LCM) and whole genome amplification (WGA) of DNA from normal breast tissue --- optimization for genome wide array analyses

I. Hedenfalk, Kristina Aaltonen, Caroline Wigerup, 2011, BMC Research Notes.

The Three Receptor Tyrosine Kinases c-KIT, VEGFR2 and PDGFRα, Closely Spaced at 4q12, Show Increased Protein Expression in Triple-Negative Breast Cancer

M. Fernö, P. Bendahl, Kristina Aaltonen, 2014, PloS one.

Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosis

Lisa Rydén, I. Hedenfalk, Kristina Aaltonen, 2012, Genes, chromosomes & cancer.

The Distribution of Circulating Tumor Cells Is Different in Metastatic Lobular Compared to Ductal Carcinoma of the Breast—Long-Term Prognostic Significance

M. Fernö, P. Bendahl, Kristina Aaltonen, 2020, Cells.

No evidence for shedding of circulating tumor cells to the peripheral venous blood as a result of mammographic breast compression

Anders Tingberg, Daniel Förnvik, Magnus Dustler, 2013, Breast Cancer Research and Treatment.

Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer

M. Fernö, Kristina Aaltonen, P. Malmström, 2014, BMC Cancer.

Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer

M. Fernö, Kristina Aaltonen, P. Malmström, 2014, BMC Cancer.

Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survival.

O. Patschan, Kristina Aaltonen, L. Rydén, 2017, Urologic oncology.

Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy

J. Karlsson, D. Gisselsson, Kristina Aaltonen, 2023, Oncoimmunology.

A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation

Kristina Aaltonen, L. Rydén, C. Welinder, 2015, Journal of Translational Medicine.

PAM50 Intrinsic Subtype Profiles in Primary and Metastatic Breast Cancer Show a Significant Shift toward More Aggressive Subtypes with Prognostic Implications

P. Bendahl, Kristina Aaltonen, L. Rydén, 2021, Cancers.

A FISH-based method for assessment of HER-2 amplification status in breast cancer circulating tumor cells following CellSearch isolation

Kristina Aaltonen, L. Rydén, Henrik Frithiof, 2016, OncoTargets and therapy.

Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer

P. Bendahl, Kristina Aaltonen, L. Rydén, 2020, Scientific Reports.

Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer

M. Fernö, Kristina Aaltonen, P. Malmström, 2014, BMC Cancer.

Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosis

I. Hedenfalk, Kristina Aaltonen, L. Rydén, 2012, Genes, chromosomes & cancer.

Association between insulin-like growth factor-1 receptor (IGF1R) negativity and poor prognosis in a cohort of women with primary breast cancer

M. Fernö, Kristina Aaltonen, P. Malmström, 2014, BMC Cancer.

Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy

P. Bendahl, Kristina Aaltonen, L. Rydén, 2017, Oncotarget.

A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation

Kristina Aaltonen, L. Rydén, C. Welinder, 2015, Journal of Translational Medicine.

Abstract P3-08-13: Serum thymidine kinase activity is an independent prognostic factor for progression-free and overall survival in women with metastatic breast cancer

P. Bendahl, Kristina Aaltonen, L. Rydén, 2018 .